Connect with us

Global Banking and Finance Review is an online platform offering news, analysis, and opinion on the latest trends, developments, and innovations in the banking and finance industry worldwide. The platform covers a diverse range of topics, including banking, insurance, investment, wealth management, fintech, and regulatory issues. The website publishes news, press releases, opinion and advertorials on various financial organizations, products and services which are commissioned from various Companies, Organizations, PR agencies, Bloggers etc. These commissioned articles are commercial in nature. This is not to be considered as financial advice and should be considered only for information purposes. It does not reflect the views or opinion of our website and is not to be considered an endorsement or a recommendation. We cannot guarantee the accuracy or applicability of any information provided with respect to your individual or personal circumstances. Please seek Professional advice from a qualified professional before making any financial decisions. We link to various third-party websites, affiliate sales networks, and to our advertising partners websites. When you view or click on certain links available on our articles, our partners may compensate us for displaying the content to you or make a purchase or fill a form. This will not incur any additional charges to you. To make things simpler for you to identity or distinguish advertised or sponsored articles or links, you may consider all articles or links hosted on our site as a commercial article placement. We will not be responsible for any loss you may suffer as a result of any omission or inaccuracy on the website. .

Trading

European stocks post worst week since October on vaccine woes

2021 01 29T070822Z 1 LYNXMPEH0S0DW RTROPTP 4 EUROPE STOCKS 1 - Global Banking | Finance

By Sruthi Shankar

(Reuters) – European stocks slid on Friday, recording their worst weekly performance since October as concerns around the slow rollout of COVID-19 vaccines mount, while a retail trading frenzy led to volatility on Wall Street.

The benchmark STOXX 600 index closed 1.9% lower, erasing all of January’s gains and ending the week down 3.1%

Germany’s DAX fell 1.7%, the UK’s blue-chip FTSE 100 dropped 1.8% and U.S. stocks fell more than 1% after underwhelming COVID-19 vaccine data from Johnson & Johnson.

Concerns around the potential economic damage from a new strain of the coronavirus in Europe and delays to vaccine rollouts have dented sentiment in the past few days.

In the U.S., where the stock market enjoyed a stimulus-led rally last year, volatility was seen following steep gains in heavily shorted stocks, including Gamestop and AMC Entertainment after retail traders piled in.

Europe’s medicines regulator approved AstraZeneca and Oxford University’s COVID-19 vaccine for people over the age of 18 on Friday, the third vaccine to be cleared for use in the European Union.

Europe urgently needs more shots to speed up its inoculation programme, with AstraZeneca, Pfizer and Moderna facing difficulties in delivering the shipments to the bloc.

“We’re postponing the recovery story a little bit because of the lockdown measures and challenges for European growth,” said Joseph Little, global chief strategist at HSBC Global Asset Management, London.

“I’m still optimistic on parts of Europe which have lagged rather badly, economically and in markets. They could begin to perform as the cyclical catch-up becomes more important.”

Economy-linked stocks of banks, insurers, miners and oil & gas companies were among the worst hit this week but Germany and Spain’s economies recorded growth in the fourth quarter, while the French economy contracted by a smaller than expected rate.

In a busy day for earnings, Sweden’s Ericsson jumped 7.6% after reporting fourth-quarter core earnings ahead of market estimates on the back of strong sales of 5G equipment.

Daimler edged up 0.9% after it said a strong fourth quarter helped it post better-than-expected 2020 group operating profit and that it was optimistic for 2021.

Swedish fashion retailer H&M fell 5.0% as it braced for a loss in the first quarter after full-year profits plummeted due to COVID-19.

Europe’s earnings season has been largely positive so far. Of the 8% of STOXX 600 companies that have reported, 78% have topped profit estimates, according to Refinitiv IBES data.

 

(Reporting by Sruthi Shankar in Bengaluru; editing by Bernard Orr and Elaine Hardcastle)

Global Banking & Finance Review

 

Why waste money on news and opinions when you can access them for free?

Take advantage of our newsletter subscription and stay informed on the go!


By submitting this form, you are consenting to receive marketing emails from: Global Banking & Finance Review │ Banking │ Finance │ Technology. You can revoke your consent to receive emails at any time by using the SafeUnsubscribe® link, found at the bottom of every email. Emails are serviced by Constant Contact

Recent Post